NO964516L - Anvendelse av et salt for fremstilling av et farmasöytisk preparat - Google Patents
Anvendelse av et salt for fremstilling av et farmasöytisk preparatInfo
- Publication number
- NO964516L NO964516L NO964516A NO964516A NO964516L NO 964516 L NO964516 L NO 964516L NO 964516 A NO964516 A NO 964516A NO 964516 A NO964516 A NO 964516A NO 964516 L NO964516 L NO 964516L
- Authority
- NO
- Norway
- Prior art keywords
- disease
- salt
- preparation
- pharmaceutical composition
- prepn
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen vedrører anvendelsen av minst ett lantanid-, mangan-, tinn-, sink-, yttrium-, kobolt-, barium- eller strontiumsalt for fremstillingen av et farmasøytisk preparat for å behandle minst ett av symptomene forbundet med de forskjellige tilstander og/eller lidelser som falger: emfysem, hoste, gastroenteritt, gastritt, intestinale spastisitetslidelser, vesikal inkontinens, cystitt, multippel sklerose. Parkinsons sykdom, Alzheimers sykdom, Korsakoffs syndrom, gastrisk ulcus, Raynauds sykdom.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512657A FR2740342B1 (fr) | 1995-10-26 | 1995-10-26 | Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964516D0 NO964516D0 (no) | 1996-10-24 |
NO964516L true NO964516L (no) | 1997-04-28 |
Family
ID=9483958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964516A NO964516L (no) | 1995-10-26 | 1996-10-24 | Anvendelse av et salt for fremstilling av et farmasöytisk preparat |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0770391B1 (no) |
JP (1) | JPH09169656A (no) |
AT (1) | ATE173933T1 (no) |
CA (1) | CA2188891A1 (no) |
DE (1) | DE69601061T2 (no) |
ES (1) | ES2127612T3 (no) |
FR (1) | FR2740342B1 (no) |
NO (1) | NO964516L (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
AT405017B (de) * | 1997-10-06 | 1999-04-26 | Jakoby Marie Luise | Mittel zur stimulation der körpereigenen abwehr |
GB0012487D0 (en) * | 2000-05-24 | 2000-07-12 | Pfylori Limited | Use of metal compounds to treat gastrointestinal infections |
DE10253634A1 (de) * | 2002-11-13 | 2004-05-27 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Endoprothese |
JP2007023010A (ja) * | 2005-07-19 | 2007-02-01 | Toshiro Azegami | 閉経後のホルモンバランス調整及びパーキンソン症の予防改善目的の経口組成物 |
AU2006274821B2 (en) * | 2005-07-29 | 2011-10-13 | Consejo Superior De Investigaciones Cientificas | Pharmaceutical compositions comprising a tungsten salt (VI) for the treatment of neurodegenerative disorders, particularly Alzheimer's disease and schizophrenia |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB997975A (en) * | 1964-01-31 | 1965-07-14 | Aristotelis Papageorgiou Lambo | Pharmaceutical compositions containing a cresol or a mixture of cresols |
GB1209093A (en) * | 1968-07-16 | 1970-10-14 | Delandale Lab Ltd | Pharmaceutical preparation |
US4386072A (en) * | 1981-06-26 | 1983-05-31 | Horrobin David F | Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor |
AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
MTP930B (en) * | 1982-04-30 | 1984-04-10 | Delandale Labs Ltd | Substained release lithium-containing tablets and method for their manufacture |
GB2133285A (en) * | 1983-01-12 | 1984-07-25 | Alec James Coppen | Pharmaceutical compositions |
GB8320203D0 (en) * | 1983-07-27 | 1983-09-01 | Horrobin D F | Anti-viral compositions |
JPS61501564A (ja) * | 1984-03-01 | 1986-07-31 | ア−ク,バ−ノン | 老人の記憶疾患の治療方法 |
GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
AU604542B2 (en) * | 1987-03-19 | 1990-12-20 | Arthropharm Pty Ltd | Polysulphated polysaccharide complexes |
JPH01172325A (ja) * | 1987-12-28 | 1989-07-07 | Terumo Corp | 抗リウマチ剤 |
JPH01287033A (ja) * | 1988-05-13 | 1989-11-17 | Terumo Corp | 抗リウマチ剤 |
JPH03120220A (ja) * | 1989-10-04 | 1991-05-22 | Natterer Siegfried | 調製薬剤およびその製造方法 |
JP3121859B2 (ja) * | 1991-05-31 | 2001-01-09 | 利博 山瀬 | 抗ウイルス剤 |
HU207799B (en) * | 1991-07-24 | 1993-06-28 | Beres Export Import Rt | Process for producing pharmaceutical composition for influencing the reticuloendothelial system, for treating chronic pain symptomes of degenerative locomotor disorders or tumors, and for treating mucoviscidosis |
JPH05117157A (ja) * | 1991-09-04 | 1993-05-14 | Kao Corp | 象牙質知覚過敏予防・治療剤及びこれを含有する口腔用組成物 |
ATE237298T1 (de) * | 1994-12-21 | 2003-05-15 | Cosmederm Technologies | Formulierungen und verfahren zur verminderung von hautirritationen |
US5716625A (en) * | 1994-12-21 | 1998-02-10 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
-
1995
- 1995-10-26 FR FR9512657A patent/FR2740342B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-14 ES ES96402181T patent/ES2127612T3/es not_active Expired - Lifetime
- 1996-10-14 DE DE69601061T patent/DE69601061T2/de not_active Expired - Fee Related
- 1996-10-14 AT AT96402181T patent/ATE173933T1/de not_active IP Right Cessation
- 1996-10-14 EP EP96402181A patent/EP0770391B1/fr not_active Expired - Lifetime
- 1996-10-24 NO NO964516A patent/NO964516L/no not_active Application Discontinuation
- 1996-10-25 CA CA002188891A patent/CA2188891A1/fr not_active Abandoned
- 1996-10-25 JP JP8284317A patent/JPH09169656A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH09169656A (ja) | 1997-06-30 |
ATE173933T1 (de) | 1998-12-15 |
CA2188891A1 (fr) | 1997-04-27 |
FR2740342A1 (fr) | 1997-04-30 |
EP0770391B1 (fr) | 1998-12-02 |
DE69601061D1 (de) | 1999-01-14 |
EP0770391A3 (fr) | 1997-05-07 |
NO964516D0 (no) | 1996-10-24 |
DE69601061T2 (de) | 1999-04-22 |
ES2127612T3 (es) | 1999-04-16 |
EP0770391A2 (fr) | 1997-05-02 |
FR2740342B1 (fr) | 1997-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964515D0 (no) | Anvendelse av et salt for fremstilling av et farmasöytisk eller dermatologisk preparat | |
IL109684A0 (en) | PHARMACEUTICAL COMPOUNDS FOR INHIBITING GASTRIC ACPharmaceutical compounds for inhibiting gastric acID SECRETION id secretion | |
SI0654264T1 (en) | Use of venlafaxine or of an aryloxy propanamine compound for the manufacture of a medicament for the treatment of urinary incontinence | |
CA2124842A1 (en) | A melt-stable lactide polymer fabric and process for manufacture thereof | |
EP0770392A3 (fr) | Utilisation de sel de lanthanide, d'étain de manganèse ou d'yttrium dans une composition pharmaceutique | |
TW221968B (no) | ||
EP0768277A4 (en) | FINE ZINC OXIDE PARTICLES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE | |
AU7129291A (en) | Clear stick anti-perspirant | |
CA2090574A1 (en) | Method of inhibiting nitric oxide formation | |
NO964516D0 (no) | Anvendelse av et salt for fremstilling av et farmasöytisk preparat | |
AU4015693A (en) | Polysuccinimide polymers and process for preparing polysuccinimide polymers | |
CA2246584A1 (en) | Method of treating tourette's syndrome | |
DE3570639D1 (en) | Method for the preparation of fine hexagonal ferrite powders, in particular, for magnetic recording | |
WO1998025905A3 (en) | Therapeutic antioxidants for alzheimer's disease | |
ATE261986T1 (de) | Polyol-aminosäureverbindungen mit aktivität gegen helicobacter pylori | |
Kashihara et al. | Halogenated Polyester Resin Composition | |
JPS5269949A (en) | Polyolefin resin composition | |
JPS52131535A (en) | Novel aromatic diamine compound and fire-retarding polyamide resinous composition containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |